These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3358422)

  • 1. Localization of the McLeod locus (XK) within Xp21 by deletion analysis.
    Bertelson CJ; Pogo AO; Chaudhuri A; Marsh WL; Redman CM; Banerjee D; Symmans WA; Simon T; Frey D; Kunkel LM
    Am J Hum Genet; 1988 May; 42(5):703-11. PubMed ID: 3358422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of the McLeod locus (XK) to a 150-380-kb region in Xp21.
    Ho MF; Monaco AP; Blonden LA; van Ommen GJ; Affara NA; Ferguson-Smith MA; Lehrach H
    Am J Hum Genet; 1992 Feb; 50(2):317-30. PubMed ID: 1734714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype.
    de Saint-Basile G; Bohler MC; Fischer A; Cartron J; Dufier JL; Griscelli C; Orkin SH
    Hum Genet; 1988 Sep; 80(1):85-9. PubMed ID: 3417309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus.
    Frey D; Mächler M; Seger R; Schmid W; Orkin SH
    Blood; 1988 Jan; 71(1):252-5. PubMed ID: 3334897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome.
    Francke U; Ochs HD; de Martinville B; Giacalone J; Lindgren V; Distèche C; Pagon RA; Hofker MH; van Ommen GJ; Pearson PL
    Am J Hum Genet; 1985 Mar; 37(2):250-67. PubMed ID: 4039107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA linkage analysis of X chromosome-linked chronic granulomatous disease.
    Baehner RL; Kunkel LM; Monaco AP; Haines JL; Conneally PM; Palmer C; Heerema N; Orkin SH
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3398-401. PubMed ID: 3010296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into extensive deletions around the XK locus associated with McLeod phenotype and characterization of two novel cases.
    Peng J; Redman CM; Wu X; Song X; Walker RH; Westhoff CM; Lee S
    Gene; 2007 May; 392(1-2):142-50. PubMed ID: 17300882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical mapping at a potential X-linked retinitis pigmentosa locus (RP3) by pulsed-field gel electrophoresis.
    Musarella MA; Anson-Cartwright CL; McDowell C; Burghes AH; Coulson SE; Worton RG; Rommens JM
    Genomics; 1991 Oct; 11(2):263-72. PubMed ID: 1769646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions.
    Francke U; Harper JF; Darras BT; Cowan JM; McCabe ER; Kohlschütter A; Seltzer WK; Saito F; Goto J; Harpey JP
    Am J Hum Genet; 1987 Mar; 40(3):212-27. PubMed ID: 2883886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of deletions spanning the Duchenne muscular dystrophy locus using a tightly linked DNA segment.
    Monaco AP; Bertelson CJ; Middlesworth W; Colletti CA; Aldridge J; Fischbeck KH; Bartlett R; Pericak-Vance MA; Roses AD; Kunkel LM
    Nature; 1985 Aug 29-Sep 4; 316(6031):842-5. PubMed ID: 2993910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign X-linked myopathy with acanthocytes (McLeod syndrome). Its relationship to X-linked muscular dystrophy.
    Swash M; Schwartz MS; Carter ND; Heath R; Leak M; Rogers KL
    Brain; 1983 Sep; 106 (Pt 3)():717-33. PubMed ID: 6685553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duchenne muscular dystrophy due to familial Xp21 deletion detectable by DNA analysis and flow cytometry.
    Wilcox DE; Cooke A; Colgan J; Boyd E; Aitken DA; Sinclair L; Glasgow L; Stephenson JB; Ferguson-Smith MA
    Hum Genet; 1986 Jun; 73(2):175-80. PubMed ID: 3721503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3.
    Brown J; Dry KL; Edgar AJ; Pryde FE; Hardwick LJ; Aldred MA; Lester DH; Boyle S; Kaplan J; Dufier JL; Ho MF; Monaco AM; Musarella MA; Wright AF
    Genomics; 1996 Oct; 37(2):200-10. PubMed ID: 8921393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series.
    Lhomme F; Peyrard T; Babinet J; Abou-Chahla W; Durieu I; Moshous D; Neven B; Rohrlich PS; Albinni S; Amiranoff D; Dumont MD; Lortholary O; Héritier S; Marguet C; Suarez F; Fischer A; Blanche S; Hermine O; Mahlaoui N
    J Clin Immunol; 2020 Jul; 40(5):752-762. PubMed ID: 32562208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum creatine phosphokinase in subjects with McLeod syndrome.
    Marsh WL; Marsh NJ; Moore A; Symmans WA; Johnson CL; Redman CM
    Vox Sang; 1981; 40(6):403-11. PubMed ID: 7197431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a random cosmid clone, cX5, which defines a new polymorphic locus DXS148 near the locus for Duchenne muscular dystrophy.
    Hofker MH; Bergen AA; Skraastad MI; Bakker E; Francke U; Wieringa B; Bartley J; van Ommen GJ; Pearson PL
    Hum Genet; 1986 Nov; 74(3):275-9. PubMed ID: 2877936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of deletions in three McLeod patients: exclusion of the XS locus from the Xp21.1-Xp21.2 region.
    El Nemer W; Colin Y; Collec E; Gane P; Cartron JP; Kim CL
    Eur J Immunogenet; 2000 Feb; 27(1):29-33. PubMed ID: 10651848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
    Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
    Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.
    Symmans WA; Shepherd CS; Marsh WL; Oyen R; Shohet SB; Linehan BJ
    Br J Haematol; 1979 Aug; 42(4):575-83. PubMed ID: 476009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg-Welander syndrome.
    Wood S; Shukin RJ; McGillivray BC; Ray PN; Worton RG
    Am J Med Genet; 1988 Feb; 29(2):419-23. PubMed ID: 2895584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.